Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations

Samuel G. Jacobson, Tomas S. Aleman, Alexander Sumaroka, Artur V. Cideciyan, Alejandro J. Roman, Elizabeth A.M. Windsor, Sharon B. Schwartz, Heidi L. Rehm, William J. Kimberling

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Purpose: To study retinal microstructure in Usher Syndrome type 1B (USH1B) caused by MYO7A mutations as a prelude to treatment initiatives. Methods: Patients with MYO7A-USH1B (n=17; ages 5-61) were studied with optical coherence tomography. Retinal laminae across horizontal and vertical meridians were measured. Colocalized visual sensitivity was measured with automated perimetry to enable comparisons of function and structure in the transition zones. Results: Laminar architecture of the central retina in MYO7A-USH1B ranged from normal to severely abnormal. Within the transition zone between normal and abnormal retina, the first detectable abnormality was an increase in prominence of the OLM (outer limiting membrane). Declining ONL thickness was accompanied by increased thickness of the OPL and normal or increased INL. Undetectable ONL and OPL and hyperthick INL were features of severe laminopathy at further eccentricities into the transition zone. Visual sensitivity in the transition zone declined with the decrease in ONL thickness. Conclusions: Patients with MYO7A-USH1B can have regions of structurally and functionally normal retina with definable tran-sitions to severe laminopathy and visual loss. The earliest detectable structural markers of disease may represent Müller glial cell response to photoreceptor stress and apoptosis. Visual losses were predictably related to a decline in ONL thickness. The prospect of focal treatment of MYO7A-USH1B, such as subretinal gene therapy, prompts the need to identify retinal locations that warrant consideration for treatment in early phase trials. The transition zones are candidate sites for treat-ment, and laminar architecture and visual sensitivity are possi-ble outcomes to assess safety and efficacy.

Original languageEnglish (US)
Pages (from-to)1886-1894
Number of pages9
JournalInvestigative Ophthalmology and Visual Science
Volume50
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Usher Syndromes
Retina
Mutation
Genes
Meridians
Visual Field Tests
Optical Coherence Tomography
Neuroglia
Genetic Therapy
Therapeutics
Type 1B Usher syndrome
Apoptosis
Safety
Membranes

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Jacobson, S. G., Aleman, T. S., Sumaroka, A., Cideciyan, A. V., Roman, A. J., Windsor, E. A. M., ... Kimberling, W. J. (2009). Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations. Investigative Ophthalmology and Visual Science, 50(4), 1886-1894. https://doi.org/10.1167/iovs.08-3122

Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations. / Jacobson, Samuel G.; Aleman, Tomas S.; Sumaroka, Alexander; Cideciyan, Artur V.; Roman, Alejandro J.; Windsor, Elizabeth A.M.; Schwartz, Sharon B.; Rehm, Heidi L.; Kimberling, William J.

In: Investigative Ophthalmology and Visual Science, Vol. 50, No. 4, 01.04.2009, p. 1886-1894.

Research output: Contribution to journalArticle

Jacobson, SG, Aleman, TS, Sumaroka, A, Cideciyan, AV, Roman, AJ, Windsor, EAM, Schwartz, SB, Rehm, HL & Kimberling, WJ 2009, 'Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations', Investigative Ophthalmology and Visual Science, vol. 50, no. 4, pp. 1886-1894. https://doi.org/10.1167/iovs.08-3122
Jacobson, Samuel G. ; Aleman, Tomas S. ; Sumaroka, Alexander ; Cideciyan, Artur V. ; Roman, Alejandro J. ; Windsor, Elizabeth A.M. ; Schwartz, Sharon B. ; Rehm, Heidi L. ; Kimberling, William J. / Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations. In: Investigative Ophthalmology and Visual Science. 2009 ; Vol. 50, No. 4. pp. 1886-1894.
@article{30f725e7f4f047e5889cfaf4930f510b,
title = "Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations",
abstract = "Purpose: To study retinal microstructure in Usher Syndrome type 1B (USH1B) caused by MYO7A mutations as a prelude to treatment initiatives. Methods: Patients with MYO7A-USH1B (n=17; ages 5-61) were studied with optical coherence tomography. Retinal laminae across horizontal and vertical meridians were measured. Colocalized visual sensitivity was measured with automated perimetry to enable comparisons of function and structure in the transition zones. Results: Laminar architecture of the central retina in MYO7A-USH1B ranged from normal to severely abnormal. Within the transition zone between normal and abnormal retina, the first detectable abnormality was an increase in prominence of the OLM (outer limiting membrane). Declining ONL thickness was accompanied by increased thickness of the OPL and normal or increased INL. Undetectable ONL and OPL and hyperthick INL were features of severe laminopathy at further eccentricities into the transition zone. Visual sensitivity in the transition zone declined with the decrease in ONL thickness. Conclusions: Patients with MYO7A-USH1B can have regions of structurally and functionally normal retina with definable tran-sitions to severe laminopathy and visual loss. The earliest detectable structural markers of disease may represent M{\"u}ller glial cell response to photoreceptor stress and apoptosis. Visual losses were predictably related to a decline in ONL thickness. The prospect of focal treatment of MYO7A-USH1B, such as subretinal gene therapy, prompts the need to identify retinal locations that warrant consideration for treatment in early phase trials. The transition zones are candidate sites for treat-ment, and laminar architecture and visual sensitivity are possi-ble outcomes to assess safety and efficacy.",
author = "Jacobson, {Samuel G.} and Aleman, {Tomas S.} and Alexander Sumaroka and Cideciyan, {Artur V.} and Roman, {Alejandro J.} and Windsor, {Elizabeth A.M.} and Schwartz, {Sharon B.} and Rehm, {Heidi L.} and Kimberling, {William J.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1167/iovs.08-3122",
language = "English (US)",
volume = "50",
pages = "1886--1894",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "4",

}

TY - JOUR

T1 - Disease boundaries in the retina of patients with usher syndrome caused by MYO7A gene mutations

AU - Jacobson, Samuel G.

AU - Aleman, Tomas S.

AU - Sumaroka, Alexander

AU - Cideciyan, Artur V.

AU - Roman, Alejandro J.

AU - Windsor, Elizabeth A.M.

AU - Schwartz, Sharon B.

AU - Rehm, Heidi L.

AU - Kimberling, William J.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Purpose: To study retinal microstructure in Usher Syndrome type 1B (USH1B) caused by MYO7A mutations as a prelude to treatment initiatives. Methods: Patients with MYO7A-USH1B (n=17; ages 5-61) were studied with optical coherence tomography. Retinal laminae across horizontal and vertical meridians were measured. Colocalized visual sensitivity was measured with automated perimetry to enable comparisons of function and structure in the transition zones. Results: Laminar architecture of the central retina in MYO7A-USH1B ranged from normal to severely abnormal. Within the transition zone between normal and abnormal retina, the first detectable abnormality was an increase in prominence of the OLM (outer limiting membrane). Declining ONL thickness was accompanied by increased thickness of the OPL and normal or increased INL. Undetectable ONL and OPL and hyperthick INL were features of severe laminopathy at further eccentricities into the transition zone. Visual sensitivity in the transition zone declined with the decrease in ONL thickness. Conclusions: Patients with MYO7A-USH1B can have regions of structurally and functionally normal retina with definable tran-sitions to severe laminopathy and visual loss. The earliest detectable structural markers of disease may represent Müller glial cell response to photoreceptor stress and apoptosis. Visual losses were predictably related to a decline in ONL thickness. The prospect of focal treatment of MYO7A-USH1B, such as subretinal gene therapy, prompts the need to identify retinal locations that warrant consideration for treatment in early phase trials. The transition zones are candidate sites for treat-ment, and laminar architecture and visual sensitivity are possi-ble outcomes to assess safety and efficacy.

AB - Purpose: To study retinal microstructure in Usher Syndrome type 1B (USH1B) caused by MYO7A mutations as a prelude to treatment initiatives. Methods: Patients with MYO7A-USH1B (n=17; ages 5-61) were studied with optical coherence tomography. Retinal laminae across horizontal and vertical meridians were measured. Colocalized visual sensitivity was measured with automated perimetry to enable comparisons of function and structure in the transition zones. Results: Laminar architecture of the central retina in MYO7A-USH1B ranged from normal to severely abnormal. Within the transition zone between normal and abnormal retina, the first detectable abnormality was an increase in prominence of the OLM (outer limiting membrane). Declining ONL thickness was accompanied by increased thickness of the OPL and normal or increased INL. Undetectable ONL and OPL and hyperthick INL were features of severe laminopathy at further eccentricities into the transition zone. Visual sensitivity in the transition zone declined with the decrease in ONL thickness. Conclusions: Patients with MYO7A-USH1B can have regions of structurally and functionally normal retina with definable tran-sitions to severe laminopathy and visual loss. The earliest detectable structural markers of disease may represent Müller glial cell response to photoreceptor stress and apoptosis. Visual losses were predictably related to a decline in ONL thickness. The prospect of focal treatment of MYO7A-USH1B, such as subretinal gene therapy, prompts the need to identify retinal locations that warrant consideration for treatment in early phase trials. The transition zones are candidate sites for treat-ment, and laminar architecture and visual sensitivity are possi-ble outcomes to assess safety and efficacy.

UR - http://www.scopus.com/inward/record.url?scp=64049105380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049105380&partnerID=8YFLogxK

U2 - 10.1167/iovs.08-3122

DO - 10.1167/iovs.08-3122

M3 - Article

C2 - 19074810

AN - SCOPUS:64049105380

VL - 50

SP - 1886

EP - 1894

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 4

ER -